CareView Communications Inc financials

CRVW CIK 0001377149

Source: EDGAR filings · Built 2026-06-19T00:43:50Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 796.53K -351.13K 686.82K -375.28K 579.52K -934.08K
EBITDA 110.71K -1.33M -353.63K -768.90K -568.34K -1.35M
Working Capital -43.48M -41.14M -37.26M -64.24M -87.16M -72.04M
Net Debt -723.25K -616.69K 19.88M 94.29M 108.04M 105.59M
Gross Margin 99.57%
Operating Margin -0.61% -19.11% -7.11% -16.08% -14.70% -28.95%
Net Margin -35.50% -56.98% -40.81% -76.48% -129.20% -180.06%
Return on Equity (ROE) 7.44% 11.63% 10.90% 7.88% 8.94% 11.31%
Return on Assets (ROA) -68.97% -129.81% -92.73% -153.07% -198.39% -212.27%
Current Ratio 0.07× 0.06× 0.07× 0.03× 0.02× 0.03×
Debt-to-Equity -0.02× -0.00× -0.58× -1.24× -0.96× -1.03×
Effective Tax Rate -0.19% 0.62% -1.92%
Cash Conversion Ratio -0.25× 0.06× -0.18× 0.06× -0.07× 0.07×
Accruals Ratio -0.86× -1.21× -1.09× -1.44× -2.12× -1.98×
SBC % of Revenue 1.55% 2.91% 2.86% 2.41%
CapEx Coverage 93.06× -6.62× 41.90× -71.32× 6.84× -5.55×
Free Cash Flow Per Share $0.00 $-0.00 $0.00 $-0.00 $0.00 $-0.01

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 9.02M 8.25M 9.68M 7.90M 7.80M 6.49M
Cost of Goods and Services Sold 28.00K
Research and Development Expense 2.41M 2.35M 2.50M 1.97M 1.71M 1.71M
Operating Expenses 9.07M 9.83M 10.37M 9.17M 8.95M 8.37M
Operating Income (Loss) -55.02K -1.58M -688.30K -1.27M -1.15M -1.88M
Income Tax Expense (Benefit) 5.96K -29.42K 74.52K
Net Income (Loss) Attributable to Parent -3.20M -4.70M -3.95M
Earnings Per Share, Basic $-0.01 $-0.01 $-0.01 $-0.04 $-0.07
Weighted Average Number of Shares Outstanding, Basic 583.88M 583.88M 448.49M 141.88M 139.38M
Earnings Per Share, Diluted $-0.01 $-0.04 $-0.07
Weighted Average Number of Shares Outstanding, Diluted 448.49M 141.88M 139.38M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 1.55M 759.27K 1.15M 420.17K 659.23K 357.95K
Assets, Current 3.21M 2.66M 2.94M 1.84M 2.18M 2.16M
Assets 4.64M 3.62M 4.26M 3.95M 5.08M 5.50M
Liabilities, Current 46.69M 43.80M 40.21M 66.08M 89.33M 74.20M
Liabilities 47.65M 44.06M 40.52M 80.61M 117.78M 108.76M
Stockholders' Equity Attributable to Parent -43.01M -40.43M -36.26M -76.66M -112.70M -103.26M
Common Stock, Shares, Outstanding 583.88M 583.88M 583.88M 141.88M 141.88M 139.38M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 805.18K -305.03K 703.61K -370.09K 678.77K -791.40K
Payments to Acquire Property, Plant, and Equipment 8.65K 46.10K 16.79K 5.19K 99.24K 142.68K
Net Cash Provided by (Used in) Investing Activities -17.57K -73.53K -62.47K -5.19K -227.49K -302.19K
Net Cash Provided by (Used in) Financing Activities 0 -8.04K -15.44K 236.21K -150.00K 1.18M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (CRVW CIK 0001377149), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

DUKRW

DUKE Robotics Corp.

NCRA

NOCERA, INC.

VRAX

Virax Biolabs Group Limited